Clinical Trial Update: A Study of LY2605541 (Insulin Peglispro) and Human Insulin Concentrations in Fat Tissue [Phase 1]

View source ↗

Summary

Phase 1 study evaluating LY2605541 (Insulin Peglispro) and human insulin concentrations in fat tissue in type 1 diabetes patients; completed with posted results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Human insulin (insulin regular (human insulin))
• LY2605541

Snippet

Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 1 | Phase 1 | Status: COMPLETED | Results posted: 2019-03-06